Login to Your Account

Financings Roundup

Tuesday, June 28, 2011
Redwood Bioscience Inc., of Burlingame, Calif., secured an undisclosed amount of funding from Takeda Ventures Inc. to further develop its precision protein-chemical engineering platform for drug conjugate optimization. The money will advance Redwood's site-specific protein modification technology for enhancing antibody-drug conjugates and peptide therapeutics.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription